Patients with high-risk prostate cancer had a significantly lower incidence of distant metastasis when treated with a ...

A study published yesterday by the journal MedComm suggests that cannabidiol (CBD) may play a protective role in bone marrow recovery following acute radiation exposure. Bone marrow, home to ...

New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and ...

In the ongoing battle against triple negative breast cancer, Vanderbilt researchers have uncovered a promising non-invasive ...

Barry Goy, MD, provides insight into the clinical implications of a retrospective analysis examining 15-year outcomes in patients with intermediate-risk prostate cancer.

A year later, at the onset of Andrew’s illness, I was a fellow at Harvard University studying trends in mortality and life ...

Adding 6 months of neoadjuvant deprivation therapy (NADT) doesn’t seem to add any benefit for patients with intermediate-risk ...

After re-staging patients, ideally with PSMA-PET, and performing a biopsy to confirm the recurrence and stratify them into risk categories, it is time to discuss local salvage treatment. Options ...

In Meraouna et al.'s study, the failure-free survival rate was 66% at 3 years of follow-up. Regarding treatment-related morbidities, 12.3% of patients experienced grade 3 genitourinary (GU) toxicity, ...

The Elekta Unity MR-LINAC system combines MRI imaging with radiation therapy to target cancerous cells with pinpoint ...

External beam radiation therapy with or without short-term androgen deprivation showed 15-year survival benefits for ...

Although carbon ion radiation led to a decline in urinary function among patients with prostate cancer, function returned to ...